Literature DB >> 1657987

EGF induces increased ligand binding affinity and dimerization of soluble epidermal growth factor (EGF) receptor extracellular domain.

D R Hurwitz1, S L Emanuel, M H Nathan, N Sarver, A Ullrich, S Felder, I Lax, J Schlessinger.   

Abstract

The binding of epidermal growth factor (EGF) to its cell surface receptor (EGF-R) results in a number of intracellular responses including the activation of the receptor intracellular tyrosine kinase. Receptor oligomerization induced by ligand binding has been suggested to play an important role in signal transduction. However, the mechanisms involved in oligomerization and signal transduction are poorly understood. We have produced and purified several milligrams of recombinant extracellular domain of the EGF receptor (EGF-Rx) using the baculovirus/insect cell expression system. The baculovirus-generated EGF-Rx is glycosylated, has had its signal peptide correctly cleaved, and exhibits a dissociation constant for EGF similar to that for solubilized full-length receptor, of about 100 nM. The binding of EGF to EGF-Rx leads to the formation of receptor dimers and higher oligomerization states which are irreversibly captured using the covalent cross-linking agent disuccinimidyl suberate. Interestingly, purified receptor monomers and dimers, stabilized by the cross-linker in the presence of EGF, exhibit increased binding affinity toward EGF as compared with receptor monomers which have not been exposed to EGF. It appears that the high affinity state of receptor can be maintained by the covalent cross-linking agent. These results indicate that in addition to ligand binding, the extracellular domain of EGF receptor possesses the inherent ability to undergo ligand-induced dimerization and that the low affinity state is converted to a high affinity state by EGF.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1657987

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Downstream processing of insect cell cultures.

Authors:  A R Bernard; M Lusti-Narasimhan; K M Radford; R S Hale; E Sebille; P Graber
Journal:  Cytotechnology       Date:  1996-01       Impact factor: 2.058

2.  Characterization of the SP11/SCR high-affinity binding site involved in self/nonself recognition in brassica self-incompatibility.

Authors:  Hiroko Shimosato; Naohiko Yokota; Hiroshi Shiba; Megumi Iwano; Tetsuyuki Entani; Fang-Sik Che; Masao Watanabe; Akira Isogai; Seiji Takayama
Journal:  Plant Cell       Date:  2007-01-12       Impact factor: 11.277

3.  Ligand-independent dimerization of oncogenic v-erbB products involves covalent interactions.

Authors:  M A Adelsman; B K Huntley; N J Maihle
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

4.  Nox5 forms a functional oligomer mediated by self-association of its dehydrogenase domain.

Authors:  Tsukasa Kawahara; Heather M Jackson; Susan M E Smith; Paul D Simpson; J David Lambeth
Journal:  Biochemistry       Date:  2011-03-04       Impact factor: 3.162

5.  The m1 muscarinic acetylcholine receptor transactivates the EGF receptor to modulate ion channel activity.

Authors:  W Tsai; A D Morielli; E G Peralta
Journal:  EMBO J       Date:  1997-08-01       Impact factor: 11.598

6.  Bivalence of EGF-like ligands drives the ErbB signaling network.

Authors:  E Tzahar; R Pinkas-Kramarski; J D Moyer; L N Klapper; I Alroy; G Levkowitz; M Shelly; S Henis; M Eisenstein; B J Ratzkin; M Sela; G C Andrews; Y Yarden
Journal:  EMBO J       Date:  1997-08-15       Impact factor: 11.598

7.  The interaction between the Drosophila secreted protein argos and the epidermal growth factor receptor inhibits dimerization of the receptor and binding of secreted spitz to the receptor.

Authors:  M H Jin; K Sawamoto; M Ito; H Okano
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

8.  A phase I study of oral ZD 1839 given daily in patients with solid tumors: IND.122, a study of the Investigational New Drug Program of the National Cancer Institute of Canada Clinical Trials Group.

Authors:  G Goss; H Hirte; W H Miller; I A J Lorimer; D Stewart; G Batist; D A E Parolin; P Hanna; S Stafford; J Friedmann; W Walsh; S Mathews; L Douglas; L K Seymour
Journal:  Invest New Drugs       Date:  2005-03       Impact factor: 3.850

9.  Physicochemical characterization of the cytoplasmic domain of the epidermal growth factor receptor and evidence for conformational changes associated with its activation by ammonium sulphate.

Authors:  M Gregoriou; P F Jones; J F Timms; J J Yang; S E Radford; A R Rees
Journal:  Biochem J       Date:  1995-03-15       Impact factor: 3.857

10.  Expression of anticardiolipin cofactor, human beta 2-glycoprotein I, by a recombinant baculovirus/insect cell system.

Authors:  M Igarashi; E Matsuura; Y Igarashi; H Nagae; Y Matsuura; K Ichikawa; T Yasuda; D R Voelker; T Koike
Journal:  Clin Exp Immunol       Date:  1993-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.